期刊
ACTA NEUROLOGICA SCANDINAVICA
卷 136, 期 -, 页码 37-44出版社
WILEY
DOI: 10.1111/ane.12840
关键词
adaptive immune response; antibodies; antibody index; JC virus; neuro-immune surveillance; progressive multifocal leukoencephalopathy
资金
- Biogen
- Teva
- Cmierix inc.
In natalizumab-treated patients without previous immunosuppressive treatment, the JCV antibody index is used to stratify PML risk. A high index value indicates that the risk to develop PML is significantly elevated, although probably about 99% of patients with this index value will not develop PML. This minireview aimed to provide an overview of the basic virology and immunology relevant to understanding JCV infections in MS patients, with a focus on what is presently known about antibodies to JCV and how they could be of use to predict and diagnose PML.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据